Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Ecuador

First Compulsory Licence Granted

April 2010 | Industry Trend Analysis

Ecuador has granted its first compulsory licence for a patented pharmaceutical since the Ecuadorian President Rafael Correa signed decree 118 on 23 October 2009.[1] The licence was granted for antiretroviral drug ritonavir, to Eskegroup, the local distributor for Cipla, an Indian generic pharmaceutical producer.

To read the full article, please choose one of the following options:

Subcribers please log in